HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Papayannidis Selected Research

Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia

6/2013Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Papayannidis Research Topics

Disease

31Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 11/2008
27Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 02/2008
12Philadelphia Chromosome
01/2022 - 12/2008
10Neoplasms (Cancer)
01/2022 - 12/2011
8Leukemia
01/2021 - 11/2008
6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 11/2015
5Residual Neoplasm
01/2021 - 05/2014
3Hematologic Neoplasms (Hematological Malignancy)
09/2020 - 03/2016
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2018 - 08/2015
2Systemic Mastocytosis
01/2022 - 11/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2016 - 08/2013
2Thrombocytopenia (Thrombopenia)
06/2015 - 06/2013
1Inflammation (Inflammations)
11/2022
1Infections
06/2022
1Bacterial Infections (Bacterial Infection)
06/2022
1Carcinogenesis
01/2022
1Erythema
01/2022
1Exanthema (Rash)
01/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1Asthenia
01/2022
1Aneuploidy (Aneuploid)
10/2021
1Tumor Lysis Syndrome
01/2021
1Lymphoma (Lymphomas)
12/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2018
1Bronchiolitis Obliterans Syndrome
12/2018
1Mastocytosis
11/2018
1Chromothripsis
01/2018
1Aseptic Meningitis
05/2016
1Disease Progression
08/2015
1Primary Myelofibrosis (Myelosclerosis)
08/2015
1Uniparental Disomy
09/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
09/2013
1Stomatitis
07/2013
1Febrile Neutropenia
07/2013

Drug/Important Bio-Agent (IBA)

17Tyrosine Kinase InhibitorsIBA
01/2022 - 11/2008
7Cytarabine (Cytosar-U)FDA LinkGeneric
07/2021 - 12/2009
5Phosphotransferases (Kinase)IBA
01/2021 - 04/2011
5Imatinib Mesylate (Gleevec)FDA Link
08/2016 - 09/2009
5Dasatinib (BMS 354825)FDA Link
08/2016 - 09/2009
4Inotuzumab OzogamicinIBA
01/2022 - 11/2018
3ponatinibIBA
01/2022 - 10/2018
3Azacitidine (5 Azacytidine)FDA Link
08/2021 - 12/2016
3glasdegibIBA
07/2021 - 08/2015
3blinatumomabIBA
01/2021 - 06/2017
3nelarabine (506U78)FDA Link
01/2021 - 08/2010
3Pharmaceutical PreparationsIBA
12/2020 - 08/2013
3Proteins (Proteins, Gene)FDA Link
10/2019 - 11/2015
3Biological ProductsIBA
01/2018 - 06/2012
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 12/2008
2SteroidsIBA
01/2022 - 01/2021
2DecitabineFDA Link
08/2021 - 01/2021
2nutlin 3IBA
04/2021 - 01/2016
2RG7388IBA
01/2021 - 05/2020
2Gemtuzumab (Mylotarg)FDA Link
09/2017 - 12/2009
2Core Binding Factors (Core-Binding Factor)IBA
09/2017 - 06/2015
2Clofarabine (Clolar)FDA Link
08/2016 - 12/2009
2Protein Isoforms (Isoforms)IBA
12/2008 - 11/2008
1Semaphorins (Semaphorin)IBA
11/2022
1AntigensIBA
10/2022
1enasidenibIBA
06/2022
1venetoclaxIBA
06/2022
1Polo-Like Kinase 1IBA
01/2022
1Aurora Kinase AIBA
01/2022
1Cyclin B1IBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1daratumumabIBA
01/2022
1ChromatinIBA
10/2021
1CohesinsIBA
10/2021
1fms-Like Tyrosine Kinase 3IBA
01/2021
1AdrenomedullinIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2020
1Etoposide (VP 16)FDA LinkGeneric
07/2020
1Mitoxantrone (Novantrone)FDA LinkGeneric
07/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1Thomsen-Friedenreich antibodiesIBA
12/2018
1Tryptases (Tryptase)IBA
11/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1adavosertibIBA
01/2018
1CI 22IBA
06/2017
1NucleotidesIBA
11/2016
1Checkpoint Kinase 1IBA
08/2016
1Mesylates (Mesylate)IBA
08/2016
1prexasertibIBA
08/2016
1RG7356IBA
05/2016
1PF 00477736IBA
11/2015
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2015
1Asparaginase (Elspar)FDA Link
08/2014
1Methotrexate (Mexate)FDA LinkGeneric
08/2014
1Aurora Kinase BIBA
07/2013
12- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
07/2013

Therapy/Procedure

22Therapeutics
10/2022 - 02/2008
10Drug Therapy (Chemotherapy)
06/2022 - 10/2015
4Stem Cell Transplantation
06/2019 - 11/2012
2Transplantation
01/2022 - 12/2018
2Salvage Therapy
08/2021 - 12/2020
2Hematopoietic Stem Cell Transplantation
01/2021 - 06/2017
1Induction Chemotherapy
05/2016
1Immunotherapy
04/2016
1Consolidation Chemotherapy
08/2014